CytoDyn Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CytoDyn Inc. stock issued during period, value, new issues for the quarter ending 2026-02-28 was $20.02M.
- CytoDyn Inc. stock issued during period, value, new issues for the quarter ending 2024-08-31 was $14.03M.
- CytoDyn Inc. stock issued during period, value, new issues for the quarter ending 2023-11-30 was $6.33M.
- CytoDyn Inc. stock issued during period, value, new issues for the quarter ending 2023-02-28 was $18.05M, a 408.02% increase year-over-year.
- CytoDyn Inc. stock issued during period, value, new issues for fiscal 2024 was $21.70M, a 41.71% decline from fiscal 2023.
- CytoDyn Inc. stock issued during period, value, new issues for fiscal 2023 was $37.22M.
- CytoDyn Inc. stock issued during period, value, new issues for fiscal 2020 was $13.41M, a 334.79% increase from fiscal 2019.
- CytoDyn Inc. stock issued during period, value, new issues for fiscal 2019 was $3.08M, a 2849.90% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-02-28 | $20.02M S-1 · filed 2026-04-22 | |
| 2025-05-31 | $14.03M S-1 · filed 2026-04-22 | |
| 2024-08-31 | $14.03M S-1 · filed 2026-04-22 | |
| 2024-05-31 | $21.70M 10-K · filed 2024-08-15 | |
| 2023-11-30 | $6.33M 10-Q · filed 2024-04-15 | |
| 2023-05-31 | $37.22M 10-K · filed 2024-08-15 | |
| 2023-02-28 | $18.05M 10-Q · filed 2023-04-10 | |
| 2022-02-28 | $3.55M 10-Q · filed 2023-04-10 | |
| 2020-05-31 | $13.41M 10-K · filed 2022-08-15 | |
| 2020-02-29 | $154.55K 10-Q · filed 2020-04-09 | |
| 2019-05-31 | $3.08M 10-K · filed 2021-07-30 | |
| 2018-05-31 | $104.55K 10-Q · filed 2019-01-09 | $104.55K 10-K · filed 2020-08-14 |
| 2012-05-31 | $3.00M 10-K · filed 2013-08-29 | |
| 2009-05-31 | $17.65K 10-K · filed 2013-08-29 | |
| 2006-05-31 | $189.55K 10-K · filed 2013-08-29 |